Needham Reiterates Buy Rating on RxSight Inc. (RXST)

September 13, 2024 6:34 AM UTC Send to a Friend
Needham analyst David Saxon reiterated a Buy rating and $66.00 price target on RxSight Inc. (NASDAQ: RXST).The analyst commented: "Earlier ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login